Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Bradykinesia

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Bradykinesia in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohno, Y1
Shimizu, S1
Imaki, J1
Ishihara, S1
Sofue, N1
Sasa, M1
Kawai, Y1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Bradykinesia

ArticleYear
Evaluation of the antibradykinetic actions of 5-HT1A agonists using the mouse pole test.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Jul-01, Volume: 32, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Disease Mod

2008